Condition
Arrhythmogenic Right Ventricular Cardiomyopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Arrhythmogenic Right Ventricular Cardiomyopathy clinical trials that are recruiting, at sites in 9 countries (most in United States (4), Germany (2), United Kingdom (2)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 9Countries
Newest Arrhythmogenic Right Ventricular Cardiomyopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| FAPI PET/CT imaging in arrhythmogenic right ventricular cardiomyopathy | — | Istanbul, Fatih | Recruiting | May 4, 2026 |
| Observing the prevalence of antibodies in patients with a specific heart condition | — | San Francisco, California and 20 other locations | Recruiting | Mar 15, 2024 |
| Gene therapy for adults with PKP2 mutation-associated heart disease | Phase 1 | San Francisco, California and 6 other locations | Recruiting | Jan 29, 2024 |
| Targeted therapy for arrhythmogenic cardiomyopathy using tideglusib | Phase 2 | Calgary, Alberta and 16 other locations | Recruiting | Dec 18, 2023 |
| Examining exercise effects on heart activity in ARVC patients | — | Zurich, Canton of Zurich | Recruiting | Sep 15, 2023 |
| Registry for patients with cardiomyopathies | — | Heidelberg, Baden-Wurttemberg | Recruiting | Feb 11, 2020 |
| Registry and biobank for arrhythmogenic ventricular cardiomyopathy | — | Rochester, Minnesota and 1 other locations | Recruiting | Feb 10, 2017 |
| Analyzing genetic mutations in pediatric cardiomyopathy | — | Indianapolis, Indiana | Recruiting | May 1, 2015 |
All recruiting trials (8)
-
FAPI PET/CT imaging in arrhythmogenic right ventricular cardiomyopathy
This study will test whether a PET/CT scan using a 68Ga-DOTA-SA-FAPI tracer can detect active scarring in adults with ARVC and provide information beyond standard heart imaging.
-
Observing the prevalence of antibodies in patients with a specific heart condition
This study looks at how common certain antibodies are in people with a heart condition called ARVC who have a specific gene mutation, while they receive regular care and share health information over five years.
-
Gene therapy for adults with PKP2 mutation-associated heart disease
This study is testing a new gene therapy called TN-401 to see if it can help adults with heart disease caused by a specific genetic mutation feel better and stay safe.
-
Targeted therapy for arrhythmogenic cardiomyopathy using tideglusib
This study is testing a new medication called tideglusib to see if it can help people with a specific genetic type of arrhythmogenic cardiomyopathy feel better and reduce their risk of serious heart problems.
-
Examining exercise effects on heart activity in ARVC patients
This study tests how different types of exercise affect heart activity in people with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) to help create safer exercise guidelines for them.
-
Registry for patients with cardiomyopathies
This study is collecting health information and samples from people with different types of heart muscle diseases to better understand their causes and effects over time.
-
Registry and biobank for arrhythmogenic ventricular cardiomyopathy
This study is trying to gather information and samples from people with arrhythmogenic ventricular cardiomyopathy and their families to better understand the genetic causes of the condition and improve early diagnosis for those at risk.
-
Analyzing genetic mutations in pediatric cardiomyopathy
This study is trying to learn more about the genetic causes of heart problems in children with cardiomyopathy to help improve diagnosis and treatment options for them.
Related topics
Quick answers
How many Arrhythmogenic Right Ventricular Cardiomyopathy clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (4 trials), Germany (2 trials), United Kingdom (2 trials), Switzerland (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.